Condition

Refractory Colorectal Adenocarcinoma clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Pidnarulex plus cemiplimab for refractory microsatellite-stable colorectal cancer.

  This tests whether combining pidnarulex with cemiplimab is safe and can help people whose microsatellite-stable colorectal cancer has stopped responding to standard treatments.

  Recruiting at 7 sites Phase 1/2 National Cancer Institute (NCI) · Aurora, Colorado and 6 other locations · NCT07147231

• Combining ZEN003694 with standard chemotherapy for advanced colorectal cancer

  This study is testing if a new drug called ZEN003694 can safely improve the effects of standard chemotherapy for people with advanced colorectal cancer that hasn't responded to other treatments.

  Recruiting at 10 sites Phase 1 National Cancer Institute (NCI) · Costa Mesa, California and 15 other locations · NCT06102902

Related topics

Quick answers

How many Refractory Colorectal Adenocarcinoma clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →